Immunomodulatory and direct activities of ropeginterferon alfa‐2b on cancer cells in mouse models of leukemia

Although ropeginterferon alfa‐2b has recently been clinically applied to myeloproliferative neoplasms with promising results, its antitumor mechanism has not been thoroughly investigated. Using a leukemia model developed in immunocompetent mice, we evaluated the direct cytotoxic effects and indirect...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakatoku, Kazuki, Nakashima, Yasuhiro, Nagasaki, Joji, Nishimoto, Mitsutaka, Hirose, Asao, Nakamae, Mika, Koh, Hideo, Hino, Masayuki, Nakamae, Hirohisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277408/
https://www.ncbi.nlm.nih.gov/pubmed/35441749
http://dx.doi.org/10.1111/cas.15376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277408/
https://www.ncbi.nlm.nih.gov/pubmed/35441749
http://dx.doi.org/10.1111/cas.15376

Ejemplares similares